0001387131-18-006726.txt : 20181210
0001387131-18-006726.hdr.sgml : 20181210
20181210200202
ACCESSION NUMBER: 0001387131-18-006726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181206
FILED AS OF DATE: 20181210
DATE AS OF CHANGE: 20181210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cartwright Daniel A
CENTRAL INDEX KEY: 0001532231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 181227583
MAIL ADDRESS:
STREET 1: 951 BROKEN SOUND PARKWAY NW
STREET 2: SUITE 320
CITY: BOCA RATON
STATE: FL
ZIP: 33487
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
BUSINESS PHONE: 561-961-1911
MAIL ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4
1
cartwright-form4_120618.xml
OWNERSHIP DOCUMENT
X0306
4
2018-12-06
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001532231
Cartwright Daniel A
6800 BROKEN SOUND PKWY NW, THIRD FLOOR
BOCA RATON
FL
33487
0
1
0
0
CFO
Common Stock
2018-12-06
4
M
0
40000
0.38
A
40000
D
Common Stock
2018-12-06
4
S
0
40000
4.57
D
40000
D
Non-Qualified Stock Option (right to buy)
0.38
2018-12-06
4
M
0
40000
0
D
2012-10-21
2021-10-21
Common Stock
40000
180000
D
The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.68, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Daniel A. Cartwright
2018-12-10